• Equistasi® clinical study accepted at the congress ISB/ASB 2019

    The study “Effects of the Equistasi® neurological rehabilitation device on Parkinson’s disease patients” conducted by a team of professors and researchers at the University of Padua was accepted at the Congress of the International Society of Biomechanics (ISB/ASB 2019). It will convene in Calgary, Canada from July 31st to August 4th. The trial was conducted

  • Equistasi® A New Device for Neurorehabilitation | Dubai 18th November

    Equistasi® will be the topic of discussion at the Conference ‘Equistasi® A New Device for Neurorehabilitation’ held at the Millennium Plaza Dubai, on November 18, 2018 at 06:00 pm. The company has put together an interesting programme for attendees. The medical staff as well as other company members will illustrate the innovative device, used for

  • New Open-Label Pilot Study: Equistasi In Childhood Ataxia

    The medical division of Bambino Gesù Ospedale Pediatrico (IRCCS), Rome, has conducted an open-label pilot study to evaluate the feasibility, safety and effectiveness of non-invasive focal mechanical vibrations (NIFMV) generated by Equistasi®. This study involved a cohort of 10 patients with childhood ataxia, a phenomenological category including different conditions still lacking of effective symptomatic therapies.

  • 25/09 International Ataxia Awareness Day

    International Ataxia Awareness Day (IAAD) is on September 25th of each year. It is a coordinated effort from individuals and Ataxia organizations around the world to help shed light on this rare disease. The theme of this year’s campaign is Ataxia symptoms. Ataxia can affect anyone, at any age. It is a degenerative neurological disease